SG001
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for SG001, covering 2021-07-30 to 2023-02-08. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety Study of First-line Treatment With SG001 Plus Chemotherapy ± Bevacizumab Versus Placebo Plus Chemotherapy ±Bevacizumab for Recurrent, or Metastatic Cervical Cancer With PD-L1 Positive (CPS≥1) [Phase 3]